Cara Therapeutics reported $503.2M in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 0.15B
Acelrx Pharmaceuticals ACRX:US $ 0.04B 0.04B
Aerie Pharmaceuticals AERI:US $ 0.44B 0.11B
Antares Pharma ATRS:US $ 0.7B 0.09B
Cara Therapeutics CARA:US $ 0.65B 0B
Chugai Pharma 4519:JP 6879.1B 607.82B
Depomed DEPO:US $ 0.13B 0.03B
Endo International Ordinary Shares ENDP:US 0.54B 0.34B
Halozyme Therapeutics HALO:US $ 5.49B 0.17B
Horizon Pharma HZNP:US 24.14B 0.3B
Johnson & Johnson JNJ:US $ 466.05B 15.69B
Neurocrine Biosciences NBIX:US $ 8.95B 0.87B
Pacira Pharmaceuticals PCRX:US $ 3.42B 0.74B
Pain Therapeutics PTIE:US $ 1.49B 0.26B
Pfizer PFE:US $ 292.38B 39.06B
Redhill Biopharma RDHL:US 0.13B 0B
Revance Therapeutics RVNC:US $ 1.4B 0.23B
Supernus Pharmaceuticals SUPN:US $ 1.72B 0.17B
Teva Pharmaceutical Industries TEVA:US 10.29B 0.72B
Vanda Pharmaceuticals VNDA:US $ 0.63B 0.24B